Evonik Venture Capital (EVC) is the corporate venture capital arm of Evonik Industries, a global leader in specialty chemicals. Established in 2012, EVC plays a strategic role in advancing Evonik's goal to become a best-in-class specialty chemicals company by investing in innovative start-ups and disruptive business models. With a fund size of €400 million, EVC has made over 55 investments since its inception, encompassing both direct and fund investments.

The investment scope ranges from early-stage to growth-stage companies, with an investment volume of up to €15 million per portfolio company. EVC's offices are located in Germany, the USA, and China, enabling it to invest in innovative technologies across various regions. The firm's investment focus includes areas such as Nutrition & Care, Smart Materials, Specialty Additives, Digitalization, and technologies supporting Evonik's Sustainability Strategy.

EVC's team comprises seasoned investment professionals with diverse backgrounds in economics, chemistry, law, and finance, committed to working closely with start-ups while respecting their independence and entrepreneurial drive. By partnering with EVC, start-ups gain access to a broad network of potential customers, technology experts, and business partners, along with strategic, technical, and commercial expertise to support their growth.